Concepedia

Andrew E. Shouksmith

AE

Statistics

Publications

8

Citations

231

H-Index

8

Active since

2015

Affiliations

University of Toronto(Current)

Huntsman Cancer Institute

University of Utah

Andrew E. Shouksmith is an author at University of Toronto specializing in pharmacology, medicinal chemistry, and cancer pharmacology.

Publications per year

2015–2021

8

Publications

8

Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia

Krimo Toutah, Nabanita Nawar, Sanna Timonen et al. · Journal of Medicinal Chemistry · 2021 · 46 citations · Full text

, , +16

PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia

Justyna M. Gawel, Andrew E. Shouksmith, Yasir S. Raouf et al. · European Journal of Medicinal Chemistry · 2020 · 41 citations · Full text

, , +8

Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer

Andrew E. Shouksmith, Fenil Shah, Michelle Grimard et al. · Journal of Medicinal Chemistry · 2019 · 37 citations · Full text

, , +10

Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype

Olasunkanmi O. Olaoye, P. R. Watson, Nabanita Nawar et al. · Journal of Medicinal Chemistry · 2021 · 28 citations · Full text

, , +11

Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)‐Resistant CML Lines While Circumventing Pharmacokinetic Liabilities

Ahmed M. Ali, Rodolfo F. Gómez‐Biagi, David A. Rosa et al. · ChemMedChem · 2016 · 26 citations · Full text

, , +14

1–5 of 8